H9N2 virus-derived M1 protein promotes H5N6 virus release in mammalian cells: Mechanism of avian influenza virus inter-species infection in humans

PLoS Pathog. 2021 Dec 3;17(12):e1010098. doi: 10.1371/journal.ppat.1010098. eCollection 2021 Dec.

Abstract

H5N6 highly pathogenic avian influenza virus (HPAIV) clade 2.3.4.4 not only exhibits unprecedented intercontinental spread in poultry, but can also cause serious infection in humans, posing a public health threat. Phylogenetic analyses show that 40% (8/20) of H5N6 viruses that infected humans carried H9N2 virus-derived internal genes. However, the precise contribution of H9N2 virus-derived internal genes to H5N6 virus infection in humans is unclear. Here, we report on the functional contribution of the H9N2 virus-derived matrix protein 1 (M1) to enhanced H5N6 virus replication capacity in mammalian cells. Unlike H5N1 virus-derived M1 protein, H9N2 virus-derived M1 protein showed high binding affinity for H5N6 hemagglutinin (HA) protein and increased viral progeny particle release in different mammalian cell lines. Human host factor, G protein subunit beta 1 (GNB1), exhibited strong binding to H9N2 virus-derived M1 protein to facilitate M1 transport to budding sites at the cell membrane. GNB1 knockdown inhibited the interaction between H9N2 virus-derived M1 and HA protein, and reduced influenza virus-like particles (VLPs) release. Our findings indicate that H9N2 virus-derived M1 protein promotes avian H5N6 influenza virus release from mammalian, in particular human cells, which could be a major viral factor for H5N6 virus cross-species infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chickens / virology
  • Humans
  • Influenza A Virus, H9N2 Subtype / genetics*
  • Influenza A virus / genetics
  • Influenza in Birds / virology*
  • Influenza, Human / virology*
  • Reassortant Viruses / genetics*
  • Viral Matrix Proteins / metabolism*
  • Viral Zoonoses / virology*
  • Virus Release

Substances

  • M1 protein, Influenza A virus
  • Viral Matrix Proteins

Grants and funding

This work was supported by the National Key Research and Development Program (2016YFD0500204) and the National Natural Science Foundation of China (31873022, 31761133003).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.